Atherosclerosis — Specific Lp(a) Apheresis for Regression of Coronary and Carotid Atherosclerosis
Citation(s)
A 72-week, Prospective, Parallel-group, Partially Blinded, Controlled Phase IIIb Study Evaluating the Impact of Specific Lp(a) Apheresis on Atherosclerotic Disease Burden in Coronary Heart Disease Patients With High Lipoprotein(a) Level.